{"id":364849,"date":"2025-09-01T04:27:08","date_gmt":"2025-09-01T04:27:08","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-anaptysbio\/"},"modified":"2025-09-01T04:27:08","modified_gmt":"2025-09-01T04:27:08","slug":"how-to-buy-anaptysbio","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/","title":{"rendered":"How to buy AnaptysBio, Inc. (ANAB) shares &#8211; Investment in AnaptysBio, Inc. (ANAB) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-364849","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy AnaptysBio, Inc. (ANAB) Shares - Investment in AnaptysBio, Inc. (ANAB) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy AnaptysBio, Inc. (ANAB) Shares - Investment in AnaptysBio, Inc. (ANAB) Stock"},"description":"Learn how to buy AnaptysBio, Inc. (ANAB) shares and discover why this biotech stock offers exciting investment opportunities in 2025 with strong clinical trial results and growth potential.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy AnaptysBio, Inc. (ANAB) shares and discover why this biotech stock offers exciting investment opportunities in 2025 with strong clinical trial results and growth potential."},"intro":"Thinking about investing in a biotech company that's making waves in autoimmune treatments? AnaptysBio, Inc. (ticker: ANAB) combines cutting-edge science with real commercial potential\u2014perfect for investors looking for growth opportunities. With groundbreaking clinical results and strategic partnerships, this company could be your ticket to the future of medicine. Let's explore everything from current stock performance to smart entry strategies.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a biotech company that's making waves in autoimmune treatments? AnaptysBio, Inc. (ticker: ANAB) combines cutting-edge science with real commercial potential\u2014perfect for investors looking for growth opportunities. With groundbreaking clinical results and strategic partnerships, this company could be your ticket to the future of medicine. Let's explore everything from current stock performance to smart entry strategies."},"body_html":"<h2>\ud83d\udcc8 Current Stock Price and Critical Dates<\/h2> <p>As of September 1, 2025, AnaptysBio, Inc. (ANAB) trades at <strong>$21.03<\/strong> on NASDAQ. Mark your calendar: <strong>November 4, 2025<\/strong> is absolutely critical\u2014that's when ANAB releases its Q3 earnings report. Historically, these reports have moved prices dramatically.<\/p> <h3>How Earnings Reports Move ANAB Stock<\/h3> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 6, 2025<\/td><td>Q2 Earnings<\/td><td>$20.50<\/td><td><strong>+8.5%<\/strong> (1 week)<\/td><\/tr> <tr><td>May 5, 2025<\/td><td>Phase 2 Data<\/td><td>$18.75<\/td><td><strong>+15.2%<\/strong> (3 days)<\/td><\/tr> <tr><td>Feb 10, 2025<\/td><td>Annual Results<\/td><td>$16.20<\/td><td><strong>+12.8%<\/strong> (beat estimates)<\/td><\/tr> <tr><td>Nov 5, 2024<\/td><td>Partnership News<\/td><td>$15.80<\/td><td><strong>+7.6%<\/strong> (investor hype)<\/td><\/tr> <tr><td>Aug 8, 2024<\/td><td>Q2 Earnings<\/td><td>$17.40<\/td><td><strong>-4.3%<\/strong> (missed targets)<\/td><\/tr> <tr><td>May 15, 2024<\/td><td>Clinical Trial Start<\/td><td>$14.90<\/td><td><strong>+3.2%<\/strong> (steady growth)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Insight<\/strong>: Positive clinical trial results (like May 2025) create explosive price movements. Earnings beats typically deliver solid 8-15% gains within days.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey (March-September 2025)<\/h2> <p>ANAB shares have experienced <strong>significant volatility<\/strong> but overall positive momentum:<\/p> <ul> <li><strong>March<\/strong>: $18.20 (post-winter consolidation)<\/li> <li><strong>May<\/strong>: $21.60 (Phase 2 rheumatoid arthritis data release)<\/li> <li><strong>July<\/strong>: $25.40 (peak after strong Q2 earnings)<\/li> <li><strong>September<\/strong>: $21.03 (current pullback from highs)<\/li> <\/ul> <p><strong>Why the rollercoaster ride?<\/strong><\/p> <ul> <li>Biotech stocks naturally swing on clinical trial news<\/li> <li>Q2 revenue more than doubled to $22.3 million (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/06\/3128719\/0\/en\/Anaptys-Announces-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html\">Q2 Financial Results<\/a>)<\/li> <li>Completed ulcerative colitis trial enrollment (<a href=\"https:\/\/www.stocktitan.net\/news\/ANAB\/anaptys-announces-second-quarter-2025-financial-results-and-provides-t9ai849p8k96.html\">Business Update<\/a>)<\/li> <\/ul> <h2>\ud83d\udd2e Price Forecast: 2025-2030<\/h2> <p><strong>2025 (Year-End)<\/strong>: $24-28 (strong Q4 clinical data expected) \u2192 <strong>BUY<\/strong><br\/> <strong>2026<\/strong>: $30-35 (ulcerative colitis approval potential)<br\/> <strong>2028<\/strong>: $45-55 (multiple pipeline successes)<br\/> <strong>2030<\/strong>: $65+ (established autoimmune treatment portfolio)<\/p> <p><strong>Verdict<\/strong>: Excellent for <strong>risk-tolerant long-term holders<\/strong>. Short-term traders should watch for post-earnings dips around November 4th.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li>Clinical trial failures could wipe out 50%+ of value overnight<\/li> <li>High cash burn rate ($38.6M quarterly loss) requires continued funding<\/li> <li>Regulatory delays common in autoimmune drug approvals<\/li> <li>Competition from larger pharma companies with deeper pockets<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li>Rosnilimab showing \"best-in-disease\" profiles in rheumatoid arthritis<\/li> <li>Potential $75M milestone payment from GSK when Jemperli hits $1B sales (<a href=\"https:\/\/www.tipranks.com\/news\/company-announcements\/anaptysbio-reports-q2-2025-financial-results-and-updates\">GSK Partnership<\/a>)<\/li> <li>Completed Phase 2 enrollment with data expected Q4 2025<\/li> <li>Strong cash position of $293.7M extends runway through 2027<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong> - Allocate no more than 5% of your portfolio to high-volatility biotech stocks<\/li> <li><strong>Dollar-cost average<\/strong> - Buy in $100-200 increments rather than one large purchase<\/li> <li><strong>Set price alerts<\/strong> - Monitor around November 4 earnings for potential entry points<\/li> <li><strong>Diversify timing<\/strong> - Consider buying half before earnings, half after results<\/li> <\/ol> <p>Humorous take: \"Trading ANAB is like dating a brilliant scientist\u2014thrilling breakthroughs mixed with occasional lab explosions. Keep your safety goggles on and enjoy the experiment!\"<\/p> <h2>\u2705 How to Buy AnaptysBio, Inc. (ANAB) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ-listed stocks<\/td><\/tr> <tr><td>2<\/td><td>Open and fund your account<\/td><td>Start with an amount you're comfortable risking<\/td><\/tr> <tr><td>3<\/td><td>Search \"ANAB\"<\/td><td>Use the ticker symbol for accurate results<\/td><\/tr> <tr><td>4<\/td><td>Select order type<\/td><td>Use limit orders to control entry price<\/td><\/tr> <tr><td>5<\/td><td>Review and confirm<\/td><td>Check commission fees before finalizing<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>Pocket Option makes stock investing accessible for everyone:<\/p> <ul> <li><strong>Minimum deposit just $5<\/strong> - Perfect for testing strategies with minimal risk<\/li> <li><strong>1-minute verification<\/strong> - Upload any ID document and start trading immediately<\/li> <li><strong>100+ withdrawal options<\/strong> - From crypto to e-wallets to bank cards<\/li> <\/ul> <p>The platform's user-friendly interface and educational resources on the <a href=\"\/blog\">Pocket Option blog<\/a> make it ideal for beginners learning how to navigate biotech investments.<\/p> <h2>\ud83c\udf0d AnaptysBio in 2025: Immunology Innovator<\/h2> <p>AnaptysBio dominates the autoimmune treatment space with their groundbreaking PD-1+ T cell targeting technology. Beyond rheumatoid arthritis, they're advancing treatments for ulcerative colitis and celiac disease. <strong>2025 fun fact<\/strong>: Their rosnilimab treatment showed such impressive results that patients maintained remission for two months after stopping medication\u2014almost unheard of in autoimmune therapies!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Current Stock Price and Critical Dates<\/h2>\n<p>As of September 1, 2025, AnaptysBio, Inc. (ANAB) trades at <strong>$21.03<\/strong> on NASDAQ. Mark your calendar: <strong>November 4, 2025<\/strong> is absolutely critical\u2014that&#8217;s when ANAB releases its Q3 earnings report. Historically, these reports have moved prices dramatically.<\/p>\n<h3>How Earnings Reports Move ANAB Stock<\/h3>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 6, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$20.50<\/td>\n<td><strong>+8.5%<\/strong> (1 week)<\/td>\n<\/tr>\n<tr>\n<td>May 5, 2025<\/td>\n<td>Phase 2 Data<\/td>\n<td>$18.75<\/td>\n<td><strong>+15.2%<\/strong> (3 days)<\/td>\n<\/tr>\n<tr>\n<td>Feb 10, 2025<\/td>\n<td>Annual Results<\/td>\n<td>$16.20<\/td>\n<td><strong>+12.8%<\/strong> (beat estimates)<\/td>\n<\/tr>\n<tr>\n<td>Nov 5, 2024<\/td>\n<td>Partnership News<\/td>\n<td>$15.80<\/td>\n<td><strong>+7.6%<\/strong> (investor hype)<\/td>\n<\/tr>\n<tr>\n<td>Aug 8, 2024<\/td>\n<td>Q2 Earnings<\/td>\n<td>$17.40<\/td>\n<td><strong>-4.3%<\/strong> (missed targets)<\/td>\n<\/tr>\n<tr>\n<td>May 15, 2024<\/td>\n<td>Clinical Trial Start<\/td>\n<td>$14.90<\/td>\n<td><strong>+3.2%<\/strong> (steady growth)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Insight<\/strong>: Positive clinical trial results (like May 2025) create explosive price movements. Earnings beats typically deliver solid 8-15% gains within days.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey (March-September 2025)<\/h2>\n<p>ANAB shares have experienced <strong>significant volatility<\/strong> but overall positive momentum:<\/p>\n<ul>\n<li><strong>March<\/strong>: $18.20 (post-winter consolidation)<\/li>\n<li><strong>May<\/strong>: $21.60 (Phase 2 rheumatoid arthritis data release)<\/li>\n<li><strong>July<\/strong>: $25.40 (peak after strong Q2 earnings)<\/li>\n<li><strong>September<\/strong>: $21.03 (current pullback from highs)<\/li>\n<\/ul>\n<p><strong>Why the rollercoaster ride?<\/strong><\/p>\n<ul>\n<li>Biotech stocks naturally swing on clinical trial news<\/li>\n<li>Q2 revenue more than doubled to $22.3 million (<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/06\/3128719\/0\/en\/Anaptys-Announces-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html\">Q2 Financial Results<\/a>)<\/li>\n<li>Completed ulcerative colitis trial enrollment (<a href=\"https:\/\/www.stocktitan.net\/news\/ANAB\/anaptys-announces-second-quarter-2025-financial-results-and-provides-t9ai849p8k96.html\">Business Update<\/a>)<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030<\/h2>\n<p><strong>2025 (Year-End)<\/strong>: $24-28 (strong Q4 clinical data expected) \u2192 <strong>BUY<\/strong><br \/> <strong>2026<\/strong>: $30-35 (ulcerative colitis approval potential)<br \/> <strong>2028<\/strong>: $45-55 (multiple pipeline successes)<br \/> <strong>2030<\/strong>: $65+ (established autoimmune treatment portfolio)<\/p>\n<p><strong>Verdict<\/strong>: Excellent for <strong>risk-tolerant long-term holders<\/strong>. Short-term traders should watch for post-earnings dips around November 4th.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li>Clinical trial failures could wipe out 50%+ of value overnight<\/li>\n<li>High cash burn rate ($38.6M quarterly loss) requires continued funding<\/li>\n<li>Regulatory delays common in autoimmune drug approvals<\/li>\n<li>Competition from larger pharma companies with deeper pockets<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li>Rosnilimab showing &#8220;best-in-disease&#8221; profiles in rheumatoid arthritis<\/li>\n<li>Potential $75M milestone payment from GSK when Jemperli hits $1B sales (<a href=\"https:\/\/www.tipranks.com\/news\/company-announcements\/anaptysbio-reports-q2-2025-financial-results-and-updates\">GSK Partnership<\/a>)<\/li>\n<li>Completed Phase 2 enrollment with data expected Q4 2025<\/li>\n<li>Strong cash position of $293.7M extends runway through 2027<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong> &#8211; Allocate no more than 5% of your portfolio to high-volatility biotech stocks<\/li>\n<li><strong>Dollar-cost average<\/strong> &#8211; Buy in $100-200 increments rather than one large purchase<\/li>\n<li><strong>Set price alerts<\/strong> &#8211; Monitor around November 4 earnings for potential entry points<\/li>\n<li><strong>Diversify timing<\/strong> &#8211; Consider buying half before earnings, half after results<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading ANAB is like dating a brilliant scientist\u2014thrilling breakthroughs mixed with occasional lab explosions. Keep your safety goggles on and enjoy the experiment!&#8221;<\/p>\n<h2>\u2705 How to Buy AnaptysBio, Inc. (ANAB) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ-listed stocks<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Open and fund your account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;ANAB&#8221;<\/td>\n<td>Use the ticker symbol for accurate results<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select order type<\/td>\n<td>Use limit orders to control entry price<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and confirm<\/td>\n<td>Check commission fees before finalizing<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>Pocket Option makes stock investing accessible for everyone:<\/p>\n<ul>\n<li><strong>Minimum deposit just $5<\/strong> &#8211; Perfect for testing strategies with minimal risk<\/li>\n<li><strong>1-minute verification<\/strong> &#8211; Upload any ID document and start trading immediately<\/li>\n<li><strong>100+ withdrawal options<\/strong> &#8211; From crypto to e-wallets to bank cards<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface and educational resources on the <a href=\"\/blog\">Pocket Option blog<\/a> make it ideal for beginners learning how to navigate biotech investments.<\/p>\n<h2>\ud83c\udf0d AnaptysBio in 2025: Immunology Innovator<\/h2>\n<p>AnaptysBio dominates the autoimmune treatment space with their groundbreaking PD-1+ T cell targeting technology. Beyond rheumatoid arthritis, they&#8217;re advancing treatments for ulcerative colitis and celiac disease. <strong>2025 fun fact<\/strong>: Their rosnilimab treatment showed such impressive results that patients maintained remission for two months after stopping medication\u2014almost unheard of in autoimmune therapies!<\/p>\n"},"faq":[{"question":"Is AnaptysBio a good long-term investment?","answer":"For investors with high risk tolerance, yes. Their pipeline shows promise, but biotech investments always carry clinical trial risks."},{"question":"What's the biggest near-term catalyst for ANAB stock?","answer":"Q4 2025 ulcerative colitis trial results could significantly move the stock price."},{"question":"How does the GSK partnership benefit AnaptysBio?","answer":"They stand to receive $75 million when Jemperli reaches $1 billion in sales, providing non-dilutive funding."},{"question":"What's a reasonable price target for 2025?","answer":"Analysts average $48 target suggests 128% upside potential from current levels."},{"question":"Should I buy before or after earnings?","answer":"Consider splitting your investment\u2014half before for potential upside surprise, half after to avoid negative surprises."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is AnaptysBio a good long-term investment?","answer":"For investors with high risk tolerance, yes. Their pipeline shows promise, but biotech investments always carry clinical trial risks."},{"question":"What's the biggest near-term catalyst for ANAB stock?","answer":"Q4 2025 ulcerative colitis trial results could significantly move the stock price."},{"question":"How does the GSK partnership benefit AnaptysBio?","answer":"They stand to receive $75 million when Jemperli reaches $1 billion in sales, providing non-dilutive funding."},{"question":"What's a reasonable price target for 2025?","answer":"Analysts average $48 target suggests 128% upside potential from current levels."},{"question":"Should I buy before or after earnings?","answer":"Consider splitting your investment\u2014half before for potential upside surprise, half after to avoid negative surprises."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy AnaptysBio, Inc. (ANAB) shares - Investment in AnaptysBio, Inc. (ANAB) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy AnaptysBio, Inc. (ANAB) shares - Investment in AnaptysBio, Inc. (ANAB) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T04:27:08+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy AnaptysBio, Inc. (ANAB) shares &#8211; Investment in AnaptysBio, Inc. (ANAB) stock\",\"datePublished\":\"2025-09-01T04:27:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/\",\"name\":\"How to buy AnaptysBio, Inc. (ANAB) shares - Investment in AnaptysBio, Inc. (ANAB) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-09-01T04:27:08+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy AnaptysBio, Inc. (ANAB) shares &#8211; Investment in AnaptysBio, Inc. (ANAB) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy AnaptysBio, Inc. (ANAB) shares - Investment in AnaptysBio, Inc. (ANAB) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/","og_locale":"en_US","og_type":"article","og_title":"How to buy AnaptysBio, Inc. (ANAB) shares - Investment in AnaptysBio, Inc. (ANAB) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T04:27:08+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy AnaptysBio, Inc. (ANAB) shares &#8211; Investment in AnaptysBio, Inc. (ANAB) stock","datePublished":"2025-09-01T04:27:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/","name":"How to buy AnaptysBio, Inc. (ANAB) shares - Investment in AnaptysBio, Inc. (ANAB) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-09-01T04:27:08+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-anaptysbio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy AnaptysBio, Inc. (ANAB) shares &#8211; Investment in AnaptysBio, Inc. (ANAB) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":364880,"slug":"how-to-buy-anaptysbio","post_title":"Comment acheter des actions AnaptysBio, Inc. (ANAB) - Investir dans les actions AnaptysBio, Inc. (ANAB)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-anaptysbio\/"},"it_IT":{"locale":"it_IT","id":364881,"slug":"how-to-buy-anaptysbio","post_title":"Come acquistare azioni AnaptysBio, Inc. (ANAB) - Investire in azioni AnaptysBio, Inc. (ANAB)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-anaptysbio\/"},"pl_PL":{"locale":"pl_PL","id":364878,"slug":"how-to-buy-anaptysbio","post_title":"Jak kupi\u0107 akcje AnaptysBio, Inc. (ANAB) - Inwestycja w akcje AnaptysBio, Inc. (ANAB)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-anaptysbio\/"},"es_ES":{"locale":"es_ES","id":364879,"slug":"how-to-buy-anaptysbio","post_title":"C\u00f3mo comprar acciones de AnaptysBio, Inc. (ANAB) - Inversi\u00f3n en acciones de AnaptysBio, Inc. (ANAB)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-anaptysbio\/"},"th_TH":{"locale":"th_TH","id":364875,"slug":"how-to-buy-anaptysbio","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 AnaptysBio, Inc. (ANAB) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 AnaptysBio, Inc. (ANAB)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-anaptysbio\/"},"tr_TR":{"locale":"tr_TR","id":364876,"slug":"how-to-buy-anaptysbio","post_title":"AnaptysBio, Inc. (ANAB) Hisseleri Nas\u0131l Al\u0131n\u0131r - AnaptysBio, Inc. (ANAB) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-anaptysbio\/"},"vt_VT":{"locale":"vt_VT","id":364874,"slug":"how-to-buy-anaptysbio","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu AnaptysBio, Inc. (ANAB) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu AnaptysBio, Inc. (ANAB)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-anaptysbio\/"},"pt_AA":{"locale":"pt_AA","id":364877,"slug":"how-to-buy-anaptysbio","post_title":"Como comprar a\u00e7\u00f5es da AnaptysBio, Inc. (ANAB) - Investimento em a\u00e7\u00f5es da AnaptysBio, Inc. (ANAB)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-anaptysbio\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/364849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=364849"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/364849\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=364849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=364849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=364849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}